EagleClaw Capital Managment, LLC

Position in SNY — Sanofi

CIK 1607636 BOSTON, MA

Position in SNY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$1,937,190

-$512,040 QoQ

Shares Held

45,410

-10.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#187

of 712 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. SNY ranks #8 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	71,774	$18,061,209
2	JNJ	Johnson & Johnson	22,283	$5,659,213
3	MRK	Merck & Co., Inc.	30,088	$3,866,308
4	NVS	Novartis AG	23,712	$3,716,144
5	PFE	Pfizer Inc	153,401	$3,693,896
6	NVO	Novo Nordisk A S	63,650	$3,051,381
7	LLY	ELI LILLY & Co	1,772	$2,125,390
8	SNY	Sanofi This page	45,410	$1,937,190

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,937,190	45,410	-10.7%	Shares	Sole	2026-08-10
2026-03-31	$2,449,230	50,835	-1.1%	Shares	Sole	2026-05-08
2025-12-31	$2,490,117	51,385	-0.6%	Shares	Sole	2026-02-10
2025-09-30	$2,439,532	51,685	-1.7%	Shares	Sole	2025-11-14
2025-06-30	$2,540,381	52,585	+14.8%	Shares	Sole	2025-08-08
2025-03-31	$2,541,454	45,825	+5.0%	Shares	Sole	2025-05-08
2024-12-31	$2,105,239	43,650	+0.9%	Shares	Sole	2025-02-07
2024-09-30	$2,493,938	43,275	+2.2%	Shares	Sole	2024-11-08
2024-06-30	$2,054,822	42,350	+2.4%	Shares	Sole	2024-08-09
2024-03-31	$2,010,825	41,375	+2.2%	Shares	Sole	2024-05-13
2023-12-31	$2,012,821	40,475	+21.5%	Shares	Sole	2024-02-14
2023-09-30	$1,786,212	33,300	+1.7%	Shares	Sole	2023-11-08
2023-06-30	$1,765,225	32,750	+4.1%	Shares	Sole	2023-08-10
2023-03-31	$1,711,509	31,450	—	Shares	Sole	2023-05-05
No filing history on record for this holder in this stock.